Clinical Trials Browser

Lymphoma, B-Cell, Marginal Zone × obinutuzumab × 30 days × Clear all

NCT05100862 2026-03-18

MAHOGANY

Phase 3 Recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT05783596 2026-03-16

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

Phase 2 Active not recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone